<p>Silencing of LINC01116 suppresses the development of oral squamous cell carcinoma by up-regulating microRNA-136 to inhibit FN1</p>

Abstract

The fundamental findings in this study collectively demonstrate that LINC01116 silencing may inhibit the progression of OSCC <i>via</i> the miR-136-mediated FN1 inhibition, highlighting a promising therapeutic strategy for OSCC treatment.